Literature DB >> 15930973

The regulation of glucose effectiveness: how glucose modulates its own production.

Julia Tonelli1, Preeti Kishore, Do-Eun Lee, Meredith Hawkins.   

Abstract

PURPOSE OF REVIEW: 'Glucose effectiveness' refers to the ability of glucose per se to suppress endogenous glucose production and stimulate glucose uptake. In addition to the inhibitory effects of insulin on endogenous glucose production, rising glucose levels have important direct effects on glucose homeostasis. The loss of glucose effectiveness in type 2 diabetes mellitus contributes importantly to hyperglycemia in those individuals. Given the rapidly increasing incidence and serious complications of type 2 diabetes mellitus, understanding the regulation of glucose effectiveness has great potential therapeutic benefits. RECENT
FINDINGS: The loss of this important regulation appears to be secondary to the chronic 'diabetic milieu' in type 2 diabetes mellitus, which includes elevated plasma glucose and free fatty acid levels. Glucose effectiveness is completely restored by normalizing plasma free fatty acid levels. Increased free fatty acid availability stimulates gluconeogenesis and alters flux through key hepatic enzymes. It is likely that at least part of this regulation is through central pathways. In addition, hormones that may exert important effects on hepatic glucose effectiveness include cortisol, insulin and glucagon-like peptide 1. The effectiveness of glucose to stimulate glucose uptake is impaired by elevated free fatty acid levels and may be enhanced by glucagon-like peptide 1.
SUMMARY: The regulation of glucose effectiveness involves a complex interplay of hormonal and metabolic factors, with free fatty acid and glucoregulatory hormones playing key roles. The loss of this regulation in type 2 diabetes mellitus contributes importantly to hyperglycemia, and may largely be caused by increased free fatty acid levels.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15930973     DOI: 10.1097/01.mco.0000172588.47811.63

Source DB:  PubMed          Journal:  Curr Opin Clin Nutr Metab Care        ISSN: 1363-1950            Impact factor:   4.294


  31 in total

1.  Ethnic differences in glucose disposal, hepatic insulin sensitivity, and endogenous glucose production among African American and European American women.

Authors:  Amy C Ellis; Jessica A Alvarez; Wesley M Granger; Fernando Ovalle; Barbara A Gower
Journal:  Metabolism       Date:  2011-11-08       Impact factor: 8.694

2.  Effects of Interrupting Children's Sedentary Behaviors With Activity on Metabolic Function: A Randomized Trial.

Authors:  Britni R Belcher; David Berrigan; Alexia Papachristopoulou; Sheila M Brady; Shanna B Bernstein; Robert J Brychta; Jacob D Hattenbach; Ira L Tigner; Amber B Courville; Bart E Drinkard; Kevin P Smith; Douglas R Rosing; Pamela L Wolters; Kong Y Chen; Jack A Yanovski
Journal:  J Clin Endocrinol Metab       Date:  2015-08-27       Impact factor: 5.958

3.  Desperately seeking sugar: glial cells as hypoglycemia sensors.

Authors:  Amira Klip; Meredith Hawkins
Journal:  J Clin Invest       Date:  2005-12       Impact factor: 14.808

4.  Impaired fasting glucose with or without impaired glucose tolerance: progressive or parallel states of prediabetes?

Authors:  Leigh Perreault; Bryan C Bergman; Mary C Playdon; Chiara Dalla Man; Claudio Cobelli; Robert H Eckel
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-06-03       Impact factor: 4.310

5.  Assessing the predictive accuracy of oral glucose effectiveness index using a calibration model.

Authors:  Michael Glicksman; Shivraj Grewal; Shrayus Sortur; Brent S Abel; Sungyoung Auh; Trudy R Gaillard; Kwame Osei; Ranganath Muniyappa
Journal:  Endocrine       Date:  2018-11-06       Impact factor: 3.633

6.  Decrease of FGF19 contributes to the increase of fasting glucose in human in an insulin-independent manner.

Authors:  J Zhang; H Li; N Bai; Y Xu; Q Song; L Zhang; G Wu; S Chen; X Hou; C Wang; L Wei; A Xu; Q Fang; W Jia
Journal:  J Endocrinol Invest       Date:  2019-03-09       Impact factor: 4.256

7.  Forkhead Box O6 (FoxO6) Depletion Attenuates Hepatic Gluconeogenesis and Protects against Fat-induced Glucose Disorder in Mice.

Authors:  Virtu Calabuig-Navarro; Jun Yamauchi; Sojin Lee; Ting Zhang; Yun-Zi Liu; Kelsey Sadlek; Gina M Coudriet; Jon D Piganelli; Chun-Lei Jiang; Rita Miller; Mark Lowe; Hideyoshi Harashima; H Henry Dong
Journal:  J Biol Chem       Date:  2015-05-05       Impact factor: 5.157

Review 8.  Mechanisms of improved glucose handling after metabolic surgery: the big 6.

Authors:  Rebecca L Paszkiewicz; Richard N Bergman
Journal:  Surg Obes Relat Dis       Date:  2016-03-14       Impact factor: 4.734

9.  Associations between central nervous system serotonin, fasting glucose, and hostility in African American females.

Authors:  Stephen H Boyle; Anastasia Georgiades; Beverly H Brummett; John C Barefoot; Ilene C Siegler; Wayne R Matson; Cynthia M Kuhn; Katherine Grichnik; Mark Stafford-Smith; Redford B Williams; Rima Kaddurah-Daouk; Richard S Surwit
Journal:  Ann Behav Med       Date:  2015-02

10.  O-GlcNAc transferase/host cell factor C1 complex regulates gluconeogenesis by modulating PGC-1α stability.

Authors:  Hai-Bin Ruan; Xuemei Han; Min-Dian Li; Jay Prakash Singh; Kevin Qian; Sascha Azarhoush; Lin Zhao; Anton M Bennett; Varman T Samuel; Jing Wu; John R Yates; Xiaoyong Yang
Journal:  Cell Metab       Date:  2012-08-08       Impact factor: 27.287

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.